» Articles » PMID: 27515051

Myofibroblasts and Inflammatory Cells As Players of Cardiac Fibrosis

Overview
Journal Arch Pharm Res
Specialty Pharmacology
Date 2016 Aug 13
PMID 27515051
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

On myocardial infarction, many cells are injured or died owing to arterial occlusion. Intracellular molecules released from injured or dead cells initiate inflammatory responses that play important roles in cardiac remodeling including fibrosis. Fibrosis is an excess accumulation of extracellular collagen. Currently, drugs used to treat cardiac fibrosis are not commercially available. Myofibroblasts are responsible for the production and secretion of collagen. Infiltrating inflammatory cells interact with fibroblasts or other cells and promote myofibroblast formation. Inflammatory cells also modulate the activities of myofibroblasts. Regulation of collagen production is critical for modulating the progression of fibrosis. Hence, the manipulation of activities of inflammatory cells and myofibroblasts will provide promising therapeutic targets for treatment of cardiac fibrosis.

Citing Articles

Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine.

Wan B, Hu J, Luo Y, Han Y, Zhang Y, Huang Q Front Pharmacol. 2025; 16:1523014.

PMID: 39931690 PMC: 11808154. DOI: 10.3389/fphar.2025.1523014.


A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.

Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R Circ Res. 2024; 136(1):26-40.

PMID: 39629565 PMC: 11692786. DOI: 10.1161/CIRCRESAHA.124.325017.


Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure.

Parichatikanond W, Duangrat R, Kurose H, Mangmool S Cells. 2024; 13(20.

PMID: 39451192 PMC: 11506672. DOI: 10.3390/cells13201674.


Transformation of macrophages into myofibroblasts in fibrosis-related diseases: emerging biological concepts and potential mechanism.

Li X, Liu Y, Tang Y, Xia Z Front Immunol. 2024; 15:1474688.

PMID: 39386212 PMC: 11461261. DOI: 10.3389/fimmu.2024.1474688.


Emerging biomedical technologies for scarless wound healing.

Cao X, Wu X, Zhang Y, Qian X, Sun W, Zhao Y Bioact Mater. 2024; 42:449-477.

PMID: 39308549 PMC: 11415838. DOI: 10.1016/j.bioactmat.2024.09.001.